These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 19323295)

  • 1. Endocrine therapy in 2009: consideration of the tumor and the host.
    Goetz MP; Ames MM; Weinshilboum M; Ingle JN
    Oncology (Williston Park); 2009 Feb; 23(2):150-1, 154. PubMed ID: 19323295
    [No Abstract]   [Full Text] [Related]  

  • 2. Predicting endocrine responsiveness: novel biomarkers on the horizon.
    Kerstann KF; Bouzyk M; Abramovitz M; Leyland-Jones B
    Oncology (Williston Park); 2009 Feb; 23(2):154, 156, 159. PubMed ID: 19323296
    [No Abstract]   [Full Text] [Related]  

  • 3. Can quantifying hormone receptor levels guide the choice of adjuvant endocrine therapy for breast cancer?
    Mackey JR
    J Clin Oncol; 2011 Apr; 29(12):1504-6. PubMed ID: 21422423
    [No Abstract]   [Full Text] [Related]  

  • 4. [Adjuvant treatment of breast cancer. Endocrine therapy].
    Mouridsen HT; Andersen J
    Ugeskr Laeger; 2007 Sep; 169(37):3072-6. PubMed ID: 17877951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting endocrine therapy responsiveness in breast cancer.
    Ma CX; Sanchez CG; Ellis MJ
    Oncology (Williston Park); 2009 Feb; 23(2):133-42. PubMed ID: 19323294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Future endocrine therapy of breast cancer].
    Ejlertsen B
    Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
    [No Abstract]   [Full Text] [Related]  

  • 7. The role of hormonal therapy in the management of hormonal-receptor-positive breast cancer with co-expression of HER2.
    Prat A; Baselga J
    Nat Clin Pract Oncol; 2008 Sep; 5(9):531-42. PubMed ID: 18607391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in adjuvant hormonal therapy for postmenopausal women.
    Strasser-Weippl K; Goss PE
    J Clin Oncol; 2005 Mar; 23(8):1751-9. PubMed ID: 15755983
    [No Abstract]   [Full Text] [Related]  

  • 9. [Long-term results of adjuvant endocrine therapy for hormone receptor-positive breast cancer].
    Semilgazov VF; Manikhas AG; Semiglazov VV; Bozhok AA; Dashian GA; Ivanov VG; Paltuev RM; Vasil'ev AG; Shchedrin DE; Ermachenkova AM; Nikitina IV; Pen'kov KD; Bessonov AA; Tabagua TT; Kolar'kova VV
    Vopr Onkol; 2011; 57(5):567-77. PubMed ID: 22238925
    [No Abstract]   [Full Text] [Related]  

  • 10. Selecting adjuvant endocrine therapy for breast cancer.
    Eneman JD; Wood ME; Muss HB
    Oncology (Williston Park); 2004 Dec; 18(14):1733-44, discussion 1744-5, 1748, 1751-4. PubMed ID: 15700624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the data, meeting patients' needs.
    Kaufmann M
    Breast; 2008 Apr; 17 Suppl 3():S1. PubMed ID: 18281217
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
    Baumann CK; Castiglione-Gertsch M
    Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adjuvant endocrine therapy for premenopausal hormone receptor-positive breast cancer; much done, more to do.
    Higgins MJ; Wolf AC
    Oncology (Williston Park); 2009 Jan; 23(1):40, 42, 44. PubMed ID: 19283920
    [No Abstract]   [Full Text] [Related]  

  • 14. Understanding resistance to tamoxifen in hormone receptor-positive breast cancer.
    Higgins MJ; Stearns V
    Clin Chem; 2009 Aug; 55(8):1453-5. PubMed ID: 19541862
    [No Abstract]   [Full Text] [Related]  

  • 15. Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.
    Fentiman IS
    Int J Clin Pract; 2006 Jun; 60(6):689-93. PubMed ID: 16805754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Adjuvant antihormonal therapy for postmenopausal women with primary operable breast cancer].
    Tuxen MK; Nielsen DL; Lindberg H; Kamby C
    Ugeskr Laeger; 2007 Jan; 169(4):297-9. PubMed ID: 17274922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Sensitivity of chemotherapy depending on hormone status in breast cancer].
    Ito Y
    Nihon Rinsho; 2007 Jun; 65 Suppl 6():568-71. PubMed ID: 17679212
    [No Abstract]   [Full Text] [Related]  

  • 18. Hormonal therapy for advanced breast cancer.
    Rugo HS
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):273-91. PubMed ID: 17512449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK; Kamby C; Nielsen DL
    Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A model citizen? Is tamoxifen more effective than aromatase inhibitors if we pick the right patients?
    Hayes DF; Stearns V; Rae J; Flockhart D;
    J Natl Cancer Inst; 2008 May; 100(9):610-3. PubMed ID: 18445818
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.